Your browser doesn't support javascript.
loading
Celecoxib repurposing in cancer therapy: molecular mechanisms and nanomedicine-based delivery technologies.
Khafaga, Asmaa F; Shamma, Rehab N; Abdeen, Ahmed; Barakat, Abdelmonem M; Noreldin, Ahmed E; Elzoghby, Ahmed O; Sallam, Marwa A.
Afiliação
  • Khafaga AF; Department of Pathology, Faculty of Veterinary Medicine, Alexandria University, Edfina, 22758, Egypt.
  • Shamma RN; Department of Pharmaceutics & Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt.
  • Abdeen A; Department of Forensic Medicine & Toxicology, Faculty of Veterinary Medicine, Benha University, Toukh, 13736, Egypt.
  • Barakat AM; Faculty of Veterinary Medicine, Damanhour University, Damanhour, 22516, Egypt.
  • Noreldin AE; Department of Histology & Cytology, Faculty of Veterinary Medicine, Damanhour University, Damanhour, 22516, Egypt.
  • Elzoghby AO; Cancer Nanotechnology Research Laboratory (CNRL), Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria, 21521, Egypt.
  • Sallam MA; Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria, 21521, Egypt.
Nanomedicine (Lond) ; 16(19): 1691-1712, 2021 08.
Article em En | MEDLINE | ID: mdl-34264123

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Idioma: En Revista: Nanomedicine (Lond) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Egito

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Idioma: En Revista: Nanomedicine (Lond) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Egito